FibroBiologics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About FibroBiologics Inc.
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.
/ 
Frequently asked questions
To buy FibroBiologics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for FibroBiologics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for FibroBiologics Inc. is FBLG:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
FibroBiologics Inc. has its primary listing on NASDAQ. You can trade FibroBiologics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, FibroBiologics Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include FibroBiologics Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like FibroBiologics Inc..